These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29279706)

  • 21. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
    Buttin BM; Powell MA; Mutch DG; Rader JS; Herzog TJ; Gibb RK; Huettner P; Edmonston TB; Goodfellow PJ
    Clin Cancer Res; 2004 Jan; 10(2):481-90. PubMed ID: 14760069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Update on Inherited Colon Cancer and Gastrointestinal Polyposis.
    Plevová P
    Klin Onkol; 2019; 32(Supplementum2):97-108. PubMed ID: 31409085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
    Ong PY; Poon SL; Tan KT; Putti TC; Ow SGW; Chen SJ; Chen CH; Lee SC
    Gynecol Oncol; 2019 Nov; 155(2):275-279. PubMed ID: 31481248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases.
    Sapalidis K; Schizas N; Lazopoulos A; Kamparoudi P; Paliouras D; Sardeli C; Konstantinou F; Chatzinikolaou F; Sarafis P; Zarogoulidis P; Kougioumtzi I; Katsikogiannis N; Karapantzos I; Karapantzou C; Laskou S; Koulouris C; Mantalobas S; Giannakidis D; Kesisoglou I; Barbetakis N
    Respir Med Case Rep; 2018; 24():5-7. PubMed ID: 29977745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
    Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A
    BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-exome sequencing in a patient with synchronous triple primary malignancies involving lung cancer: a case report.
    Li D; Yu M; Zhou P; Yang J; Wang Y
    Precis Clin Med; 2020 Dec; 3(4):306-310. PubMed ID: 35692627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
    Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
    PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic characterization of early onset ovarian carcinoma.
    Bernards SS; Norquist BM; Harrell MI; Agnew KJ; Lee MK; Walsh T; Swisher EM
    Gynecol Oncol; 2016 Feb; 140(2):221-5. PubMed ID: 26718727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome.
    Rashid MU; Naeemi H; Muhammad N; Loya A; Yusuf MA; Lubiński J; Jakubowska A; Hamann U
    Hered Cancer Clin Pract; 2016; 14():14. PubMed ID: 27413415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metachronous Sporadic Sextuple Primary Malignancies Including Bilateral Breast Cancers.
    Hwang KT; Kim MJ; Chu AJ; Park JH; Kim J; Lee JY; Choi IS; Park JH; Chang JH; Hwang KR
    J Breast Cancer; 2020 Aug; 23(4):438-446. PubMed ID: 32908793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid cancer in a patient with Lynch syndrome - case report and literature review.
    Fazekas-Lavu M; Parker A; Spigelman AD; Scott RJ; Epstein RJ; Jensen M; Samaras K
    Ther Clin Risk Manag; 2017; 13():915-918. PubMed ID: 28769567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus.
    Klairmont M; Kopkash K; Favuzza J; Hill M; Rao R; Mahon B; Seder CW
    Anticancer Res; 2015 Nov; 35(11):6159-62. PubMed ID: 26504043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.
    Caminsky NG; Mucaki EJ; Perri AM; Lu R; Knoll JH; Rogan PK
    Hum Mutat; 2016 Jul; 37(7):640-52. PubMed ID: 26898890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.
    Dhooge M; Baert-Desurmont S; Corsini C; Caron O; Andrieu N; Berthet P; Bonadona V; Cohen-Haguenauer O; De Pauw A; Delnatte C; Dussart S; Lasset C; Leroux D; Maugard C; Moretta-Serra J; Popovici C; Buecher B; Colas C; Noguès C;
    Eur J Med Genet; 2020 Dec; 63(12):104080. PubMed ID: 33039684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
    Hauke J; Hahnen E; Schneider S; Reuss A; Richters L; Kommoss S; Heimbach A; Marmé F; Schmidt S; Prieske K; Gevensleben H; Burges A; Borde J; De Gregorio N; Nürnberg P; El-Balat A; Thiele H; Hilpert F; Altmüller J; Meier W; Dietrich D; Kimmig R; Schoemig-Markiefka B; Kast K; Braicu E; Baumann K; Jackisch C; Park-Simon TW; Ernst C; Hanker L; Pfisterer J; Schnelzer A; du Bois A; Schmutzler RK; Harter P
    J Med Genet; 2019 Sep; 56(9):574-580. PubMed ID: 30979843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
    Angeli D; Salvi S; Tedaldi G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1.
    Maruyama A; Miyamoto S; Saito T; Kondo H; Baba H; Tsukamoto N
    Cancer; 2001 Jun; 91(11):2056-64. PubMed ID: 11391585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature.
    Nottegar A; Luchini C; Cingarlini S; Beccari S; Grego E; Gilioli E; Manfrin E; Bonetti F
    Pathologica; 2016 Dec; 108(4):164-168. PubMed ID: 28195257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.